• Retail Suite Media

Imperial Logistics joins global campaign to fight the threat of fake medicines

As a leading force in African healthcare supply chain management, as well as pharmaceutical wholesale and distribution, Imperial Logistics is committed to addressing the public health threats that stem from fake medicines. The company recently added impetus to its efforts by joining forces with global action campaign “Fight the Fakes” through its relationship with IFPW, the global trade association for pharmaceutical wholesalers and distributors.

“This powerful campaign aims to raise awareness about the dangers of fake medicines, and we are proud to join a global movement of organisations and individuals who are striving to highlight the issue of fake medicines, and fight this threat around the globe,” comments Imperial Logistics chief strategy officer Cobus Rossouw.

Nearly any type of pharmaceutical product can be and has been falsified: whether 'lifestyle' medicines, including erectile dysfunction and weight loss medicines, or lifesaving medicines, including those used to treat malaria, tuberculosis, HIV/AIDS, cancer, heart disease, diabetes and other life-threatening conditions.

More than 500 fake versions of pharmaceutical products are currently circulating. Some estimates put the number of deaths by falsified medicines at 700 000 per year. In addition, online sale of medicines is an increasing international threat, as there are more than 40 000 “active rogue online pharmacies” at active at any one time.

“As a global campaign that unites partners active along the supply chain, and that provides accurate information on the risks of falsified medicines, Fight the Fakes supports the WHO and others by explaining how to avoid fakes, how to spot them and how to report suspicious products,” Rossouw expands. “Fake medicines are everybody’s business, and a comprehensive strategy to combat the manufacturing and distribution of fake medicines requires active participation by all stakeholders,” he concludes.



Choose Your Preferred Publication
  • Instagram
  • Facebook
  • LinkedIn